{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:18:57Z","timestamp":1778692737057,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["1Y374"],"award-info":[{"award-number":["1Y374"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005329","name":"Guizhou Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["(2019)1257"],"award-info":[{"award-number":["(2019)1257"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803623"],"award-info":[{"award-number":["81803623"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1812403"],"award-info":[{"award-number":["U1812403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.toxlet.2022.11.023","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:46:41Z","timestamp":1669902401000},"page":"152-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Evaluating and predicting the correlations of hepatic concentration and pyrrole-protein adduction with hepatotoxicity induced by retrorsine based on pharmacokinetic\/pharmacodynamic model"],"prefix":"10.1016","volume":"373","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.toxlet.2022.11.023_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4102\/jsava.v78i3.302","article-title":"The toxicity of Senecio inaequidens DC","volume":"78","author":"Dimande","year":"2007","journal-title":"J. South Afr. Vet. Assoc."},{"key":"10.1016\/j.toxlet.2022.11.023_bib2","first-page":"11563","article-title":"Risk assessment of pyrrolizidine alkaloids in food of plant and animal origin","author":"Dusemund","year":"2018","journal-title":"Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"issue":"1","key":"10.1016\/j.toxlet.2022.11.023_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/tx500403t","article-title":"Pyrrolizidine alkaloids: potential role in the etiology of cancers, pulmonary hypertension, congenital anomalies, and liver disease","volume":"28","author":"Edgar","year":"2015","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.toxlet.2022.11.023_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DMR-120028426","article-title":"Pyrrolizidine alkaloids--genotoxicity, metabolism enzymes, metabolic activation, and mechanisms","volume":"36","author":"Fu","year":"2004","journal-title":"Drug Metab. Rev."},{"issue":"6","key":"10.1016\/j.toxlet.2022.11.023_bib5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/acs.chemrestox.9b00038","article-title":"1-Formyl-7-hydroxy-6,7-dihydro-5H-pyrrolizine (1-CHO-DHP): a potential proximate carcinogenic metabolite of pyrrolizidine alkaloids","volume":"32","author":"He","year":"2019","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.toxlet.2022.11.023_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00204-020-02921-0","article-title":"Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites","volume":"95","author":"He","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.toxlet.2022.11.023_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","article-title":"Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome","volume":"23","author":"Helmy","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.toxlet.2022.11.023_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02354287","article-title":"A semicompartmental modeling approach for pharmacodynamic data assessment","volume":"23","author":"Kowalski","year":"1995","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.toxlet.2022.11.023_bib9","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4798","article-title":"Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits","author":"Kura","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.toxlet.2022.11.023_bib10","article-title":"Toxicokinetic and bioavailability studies on retrorsine in mice, and ketoconazole-induced alteration in toxicokinetic properties","author":"Li","year":"2021","journal-title":"Biomed. Chromatogr."},{"issue":"3","key":"10.1016\/j.toxlet.2022.11.023_bib11","first-page":"127","article-title":"Immunoassay approach for diagnosis of exposure to pyrrolizidine alkaloids","volume":"35","author":"Li","year":"2017","journal-title":"J. Environ. Sci. Health Part C., Environ. Carcinog. Ecotoxicol. Rev."},{"issue":"4","key":"10.1016\/j.toxlet.2022.11.023_bib12","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","article-title":"Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum","volume":"54","author":"Lin","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2022.11.023_bib13","first-page":"129391","article-title":"Development of a two-layer transwell co-culture model for the in vitro investigation of pyrrolizidine alkaloid-induced hepatic sinusoidal damage","author":"Lu","year":"2019","journal-title":"Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"issue":"6","key":"10.1016\/j.toxlet.2022.11.023_bib14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/acs.chemrestox.8b00369","article-title":"Pyrrole-Hemoglobin Adducts, a more feasible potential biomarker of pyrrolizidine alkaloid exposure","volume":"32","author":"Ma","year":"2019","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.toxlet.2022.11.023_bib15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00204-020-02947-4","article-title":"Clinical application of pyrrole-hemoglobin adducts as a biomarker of pyrrolizidine alkaloid exposure in humans","volume":"95","author":"Ma","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.toxlet.2022.11.023_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/096228029900800304","article-title":"A regulatory perspective on pharmacokinetic\/pharmacodynamic modelling","volume":"8","author":"Machado","year":"1999","journal-title":"Stat. Methods Med. Res."},{"issue":"6","key":"10.1016\/j.toxlet.2022.11.023_bib17","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/tx500071q","article-title":"Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis","volume":"27","author":"Ruan","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"5","key":"10.1016\/j.toxlet.2022.11.023_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.coph.2008.06.010","article-title":"PK\/PD: new insights for antibacterial and antiviral applications","volume":"8","author":"Schmidt","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.toxlet.2022.11.023_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cpt1979253358","article-title":"Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine","volume":"25","author":"Sheiner","year":"1979","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.toxlet.2022.11.023_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/26896583.2020.1743608","article-title":"Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids","volume":"38","author":"Song","year":"2020","journal-title":"J. Environ. Sci. Health Part C., Toxicol. Carcinog."},{"issue":"1","key":"10.1016\/j.toxlet.2022.11.023_bib21","first-page":"95","article-title":"Pyrrolizidine alkaloid plants, metabolism and toxicity","volume":"8","author":"Stegelmeier","year":"1999","journal-title":"J. Nat. toxins"},{"issue":"6","key":"10.1016\/j.toxlet.2022.11.023_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF01062109","article-title":"Statistical moments in pharmacokinetics","volume":"6","author":"Yamaoka","year":"1978","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"8","key":"10.1016\/j.toxlet.2022.11.023_bib23","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00204-019-02499-2","article-title":"Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids","volume":"93","author":"Yang","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.toxlet.2022.11.023_bib24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1021\/acs.chemrestox.6b00260","article-title":"Comparative Study of Hepatotoxicity of Pyrrolizidine Alkaloids Retrorsine and Monocrotaline","volume":"30","author":"Yang","year":"2017","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.toxlet.2022.11.023_bib25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41598-020-80272-7","article-title":"Pharmacokinetics and pharmacodynamics integration of danofloxacin against Eschrichia coli in piglet ileum ultrafiltration probe model","volume":"11","author":"Yang","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427422018057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427422018057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:51:31Z","timestamp":1778691091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427422018057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":25,"alternative-id":["S0378427422018057"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2022.11.023","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating and predicting the correlations of hepatic concentration and pyrrole-protein adduction with hepatotoxicity induced by retrorsine based on pharmacokinetic\/pharmacodynamic model","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2022.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}